DeStefano Anita L, Larson Martin G, Mitchell Gary F, Benjamin Emelia J, Vasan Ramachandran S, Li Jiang, Corey Diane, Levy Daniel
Department of Biostatistics, Boston University School of Public Health, 715 Albany Street, T418E, Boston, Mass 02118, USA.
Hypertension. 2004 Aug;44(2):152-5. doi: 10.1161/01.HYP.0000135248.62303.81. Epub 2004 Jun 21.
The objective of this study was to assess heritability and identify chromosomal regions showing evidence of linkage to pulse pressure (PP), a simple indicator of proximal conduit vessel stiffness. Blood pressure data were analyzed for 8478 members of the National Heart, Lung and Blood Institute's (NHLBI) Framingham Heart Study. Long-term PP was defined using 2-stage analysis. First, the difference between systolic and diastolic blood pressure was averaged over all qualifying clinic examinations. In the second stage, mean PP was adjusted for mean age, time period of examination, and body mass index by regression analysis. PP values were available for 6421 individuals in 1593 families for heritability estimation and for 2492 individuals in 330 families for linkage analysis. Microsatellite markers covering the genome at 10 cM intervals were typed by the NHLBI Mammalian Genotyping Service; genome scan data were available on 1585 individuals with PP data. Heritability estimates of long-term PP accounting for hypertension treatment and for ignoring treatment were 0.52 and 0.51, respectively. Variance component linkage analysis identified several locations with suggestive evidence of linkage: chromosome 15 at 122 cM (logarithm of odds [LOD]=2.94), chromosome 7 at 71 cM (LOD=2.42), chromosome 5 at 53 cM (LOD=2.03), and chromosome 10 at 81 cM (LOD=1.83) for PP accounting for treatment. LOD scores were slightly lower when ignoring treatment, with the exception of a peak on chromosome 10 at 81 cM (LOD=2.58). In conclusion, we have demonstrated a substantial genetic component to PP and have identified 4 chromosomal regions that may harbor genes influencing vascular stiffness.
本研究的目的是评估遗传力,并确定显示出与脉压(PP)存在连锁证据的染色体区域,脉压是近端血管硬度的一个简单指标。对美国国立心肺血液研究所(NHLBI)弗雷明汉心脏研究的8478名成员的血压数据进行了分析。长期脉压采用两阶段分析进行定义。首先,在所有符合条件的临床检查中,计算收缩压与舒张压之差的平均值。在第二阶段,通过回归分析对平均脉压进行平均年龄、检查时间段和体重指数的校正。有6421名个体来自1593个家庭的脉压值可用于遗传力估计,有2492名个体来自330个家庭的脉压值可用于连锁分析。由NHLBI哺乳动物基因分型服务机构对覆盖基因组、间隔为10厘摩(cM)的微卫星标记进行分型;有1585名有脉压数据个体的基因组扫描数据。考虑高血压治疗和不考虑治疗时,长期脉压的遗传力估计值分别为0.52和0.51。方差成分连锁分析确定了几个有连锁提示证据的位置:考虑治疗时,122厘摩处的15号染色体(优势对数[LOD]=2.94)、71厘摩处的7号染色体(LOD=2.42)、53厘摩处的5号染色体(LOD=2.03)以及81厘摩处的10号染色体(LOD=1.83)与脉压相关。不考虑治疗时,LOD分数略低,但81厘摩处10号染色体上有一个峰值(LOD=2.58)除外。总之,我们证明了脉压有很大的遗传成分,并确定了4个可能含有影响血管硬度基因的染色体区域。